Tiny needle, big hope: new eye surgery trial for sudden blindness

NCT ID NCT07151755

Recruiting now Disease control Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This trial tests a new procedure for people who suddenly lose vision due to a blocked artery in the eye. Surgeons will use a tiny microneedle to deliver clot-busting medicine directly into the artery during eye surgery. The study will compare this approach to standard care in 24 participants, tracking vision recovery over one year.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: thrombolytic agent delivered via microneedle
What this could lead to: If it works, this could offer a new way to restore vision after a blockage in the eye's main artery.
What could go wrong: This is a very small, early-stage trial with only 24 people. The procedure is invasive and carries risks like bleeding or infection. Success is not guaranteed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRANCH RETINAL ARTERY OCCLUSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

branch retinal artery occlusion central retinal artery occlusion retinal artery occlusion

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CENTRAL RETINAL ARTERY OCCLUSION

Contacts and locations

Locations

Eye Center of the Second Affiliated Hospital of Zhejiang University
RECRUITING

Hangzhou, Zhejiang, 310058, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.